110 related articles for article (PubMed ID: 2480314)
1. Growth of hemopoietic cells after incubation with VP 16-213.
Schulze E; Hofmann U; Woetzel M; Helbig W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):591-6. PubMed ID: 2480314
[TBL] [Abstract][Full Text] [Related]
2. Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow.
Chao NJ; Aihara M; Blume KG; Sikic BI
Exp Hematol; 1990 Dec; 18(11):1193-8. PubMed ID: 2226679
[TBL] [Abstract][Full Text] [Related]
3. Effects of verapamil on etoposide, vincristine, and adriamycin activity in normal human bone marrow granulocyte-macrophage progenitors and in human K562 leukemia cells in vitro.
Yalowich JC; Zucali JR; Gross M; Ross WE
Cancer Res; 1985 Oct; 45(10):4921-4. PubMed ID: 3861238
[TBL] [Abstract][Full Text] [Related]
4. Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission.
Martin H; Bruecher J; Claudé R; Hoelzer D
Bone Marrow Transplant; 1993 Nov; 12(5):495-9. PubMed ID: 8298560
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
Lagneaux L; Marie JP; Delforge A; Socquet M; Thevenin D; Zittoun R; Stryckmans P
Exp Hematol; 1989 Aug; 17(7):843-6. PubMed ID: 2753092
[TBL] [Abstract][Full Text] [Related]
7. Granulocytopoiesis in children with acute lymphoblastic leukaemia.
Vladimirskaya EB; Shersheneva NS; Sallam S; Zamaraeva NV; Chukanin SN
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):383-90. PubMed ID: 1703107
[TBL] [Abstract][Full Text] [Related]
8. Assessment of purging with multidrug resistance (MDR) modulators and VP-16: results of long-term marrow culture.
Aihara M; Sikic BI; Blume KG; Chao NJ
Exp Hematol; 1990 Sep; 18(8):940-4. PubMed ID: 2387345
[TBL] [Abstract][Full Text] [Related]
9. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
[TBL] [Abstract][Full Text] [Related]
10. Alterations in CFU-GM growth in preleukaemic and leukaemic AKR/J mice.
Alonso MC; Torres A; Solana R; Manzanares MR; Garcia-Castellano JM; Peña J
Folia Biol (Praha); 1985; 31(3):193-9. PubMed ID: 4018306
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the sensitivity of normal and leukaemic myeloid progenitors to in-vitro incubation with cytotoxic drugs: a study of pharmacological purging.
Singer CR; Linch DC
Leuk Res; 1987; 11(11):953-9. PubMed ID: 3320579
[TBL] [Abstract][Full Text] [Related]
12. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
[TBL] [Abstract][Full Text] [Related]
13. CFU-gm colony formation of peripheral blood and bone marrow in adult acute leukemia at presentation, during remission, and at relapse.
Jehn U; Wachholz K
Int J Cell Cloning; 1985 Jul; 3(4):199-213. PubMed ID: 3860564
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
[TBL] [Abstract][Full Text] [Related]
15. The xid mutation affects hemopoiesis in long term cultures of murine bone marrow.
Hayashi S; Witte PL; Kincade PW
J Immunol; 1989 Jan; 142(2):444-51. PubMed ID: 2911009
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis.
Chang TT; Gulati SC; Chou TC; Vega R; Gandola L; Ibrahim SM; Yopp J; Colvin M; Clarkson BD
Cancer Res; 1985 Jun; 45(6):2434-9. PubMed ID: 3857119
[TBL] [Abstract][Full Text] [Related]
17. Effect of retinoic acid on the clonal growth of childhood myeloid and lymphoid leukemias: a pediatric oncology group study.
Findley HW; Steuber CP; Ruymann FB; Culbert S; Ragab AH
Exp Hematol; 1984 Nov; 12(10):768-73. PubMed ID: 6334611
[TBL] [Abstract][Full Text] [Related]
18. Hemotoxicity by prolonged etoposide administration to mice can be prevented by simultaneous growth factor therapy.
de Haan G; Engel C; Dontje B; Loeffler M; Nijhof W
Cancer Res; 1995 Jan; 55(2):324-9. PubMed ID: 7529132
[TBL] [Abstract][Full Text] [Related]
19. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
Tamayo E; Hervé P
Exp Hematol; 1988 Feb; 16(2):97-101. PubMed ID: 3276544
[TBL] [Abstract][Full Text] [Related]
20. Growth of normal versus leukemic bone marrow cells in long term culture from acute lymphoblastic and myeloblastic leukemias.
Schiró R; Coutinho LH; Will A; Chang J; Testa NG; Dexter TM
Blut; 1990 Nov; 61(5):267-70. PubMed ID: 2271773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
